Evidence map›Paper›PMID 41341719›Full record

ArticleResearch (Washington, D.C.)2025

DTBind: A Mechanism-Driven Deep Learning Framework for Accurate Prediction of Drug-Target Molecular Recognition.

Qiuyu Li, Zeyu Xu, Yanhao Zhu, Wanyun Zhou, Mingming Guan, Shiqing Zhao, Mengyuan Liu, Bin Liu, Juntao Liu

Abstract read
In one paragraph

Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qiuyu LiSchool of Mathematics and Statistics, Shandong University, Weihai 264209, China.
Zeyu XuSchool of Mathematics and Statistics, Shandong University, Weihai 264209, China.
Yanhao ZhuSchool of Mathematics and Statistics, Shandong University, Weihai 264209, China.
Wanyun ZhouThe Hong Kong University of Science and Technology (Guangzhou), Guangzhou 511453, China.
Mingming GuanSchool of Mathematics and Statistics, Shandong University, Weihai 264209, China.
Shiqing ZhaoSchool of Mathematics and Statistics, Shandong University, Weihai 264209, China.
Mengyuan LiuSchool of Mathematics and Statistics, Shandong University, Weihai 264209, China.
Bin LiuDepartment of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
Juntao LiuSchool of Mathematics and Statistics, Shandong University, Weihai 264209, China.ORCID https://orcid.org/0000-0002-7296-906X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate prediction of drug-target molecular recognition is essential for early-stage drug discovery, spanning binding occurrence, binding site localization, and binding affinity estimation. However, current approaches frequently treat these tasks independently, thereby overlooking the shared mechanistic principles that underlie them. We present DTBind, a unified and mechanism-driven framework that hierarchically adapts to sequence, structure, and complex-level inputs for predicting binding occurrence, site, and affinity, grounded in the shared mechanistic determinants of molecular recognition. Comprehensive benchmarking demonstrates that DTBind achieves superior performance over state-of-the-art methods in terms of accuracy and generalizability. Analysis of hierarchical protein encodings demonstrates that determinant-based protein representations gradually drive the accurate prediction of molecular recognition. Validation based on molecular dynamics simulations shows that DTBind reliably predicts drug-target binding regions for 3 famous proteins that lack experimental structures.

Identifiers

PMID41341719
PMCPMC12669800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.